Caris Life Sciences, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $757.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $16.3M | 2.1% |
| Working Capital | $9.5M | 1.2% |
| Net Cash Flow | $732.0M | 96.6% |
Net Cash Flow Breakdown
Total Cash from Operations: $757.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $16.3M | 2.1% |
| Working Capital | $9.5M | 1.2% |
| Net Cash Flow | $732.0M | 96.6% |